Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk.
OBJECTIVES: Genome-wide association studies have dramatically increased the number of common genetic variants that are robustly associated with type 2 diabetes. A possible clinical use of this information is to identify individuals at high risk of developing the disease, so that preventative measur...
Κύριοι συγγραφείς: | Lango, H, Palmer, C, Morris, A, Zeggini, E, Hattersley, A, McCarthy, M, Frayling, T, Weedon, M |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2008
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Large-scale replication typing of modest signals from genome-wide association studies identifies additional type 2 diabetes susceptibility variants in the IGF2BP2 and VEGFA genes
ανά: Zeggini, E, κ.ά.
Έκδοση: (2007) -
Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes.
ανά: Rafiq, S, κ.ά.
Έκδοση: (2008) -
Fine-mapping type 2 diabetes causal variants on chromosome 9p21 in 2000 UK cases and 3000 unselected controls
ανά: Morris, A, κ.ά.
Έκδοση: (2008) -
Interrogating type 2 diabetes genome-wide association data using a biological pathway-based approach.
ανά: Perry, JR, κ.ά.
Έκδοση: (2009) -
Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function.
ανά: Pascoe, L, κ.ά.
Έκδοση: (2007)